238 related articles for article (PubMed ID: 7946800)
1. Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies.
Morgan K
Br Heart J; 1994 Sep; 72(3 Suppl):S3-10. PubMed ID: 7946800
[No Abstract] [Full Text] [Related]
2. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
[TBL] [Abstract][Full Text] [Related]
3. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
Mori J; Zhang L; Oudit GY; Lopaschuk GD
J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
[TBL] [Abstract][Full Text] [Related]
4. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
Schunkert H; Holmer SR; Riegger G
Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction.
Pfeffer JM; Fischer TA; Pfeffer MA
Annu Rev Physiol; 1995; 57():805-26. PubMed ID: 7778884
[No Abstract] [Full Text] [Related]
6. Endothelial dysfunction in heart failure and potential for reversal by ACE inhibition.
Drexler H
Br Heart J; 1994 Sep; 72(3 Suppl):S11-4. PubMed ID: 7946797
[No Abstract] [Full Text] [Related]
7. Interactions among ACE, kinins and NO.
Linz W; Wohlfart P; Schölkens BA; Malinski T; Wiemer G
Cardiovasc Res; 1999 Aug; 43(3):549-61. PubMed ID: 10690327
[No Abstract] [Full Text] [Related]
8. The renin-angiotensin system as a target for therapeutic intervention.
Swales JD
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S1-5. PubMed ID: 7898088
[TBL] [Abstract][Full Text] [Related]
9. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
[TBL] [Abstract][Full Text] [Related]
10. Effect of ACE inhibition on myocardial ischaemia.
Ferrari R
Eur Heart J; 1998 Sep; 19 Suppl J():J30-5. PubMed ID: 9796838
[TBL] [Abstract][Full Text] [Related]
11. Tissue angiotensin converting enzyme inhibition. Relevant to clinical practice?
Lees KR; MacFadyen RJ; Reid JL
Am J Hypertens; 1990 Nov; 3(11):266S-272S. PubMed ID: 2175623
[TBL] [Abstract][Full Text] [Related]
12. [Intervention in the renin-angiotensin and kallikrein-kinin systems. Pharmacologic basis of the action of ACE inhibitors].
Linz W; Busch AE
Pharm Unserer Zeit; 2003; 32(1):18-22. PubMed ID: 12577756
[No Abstract] [Full Text] [Related]
13. ACE inhibition in the tissues.
Unger T; Gohlke P
Clin Physiol Biochem; 1992; 9(3):89-93. PubMed ID: 1338777
[TBL] [Abstract][Full Text] [Related]
14. Tissue angiotensin II and myocardial infarction.
Sun Y; Weber KT
EXS; 1996; 76():479-88. PubMed ID: 8805813
[No Abstract] [Full Text] [Related]
15. Mechanism of protective effects of ACE inhibition on coronary artery disease.
Dzau VJ
Eur Heart J; 1998 Sep; 19 Suppl J():J2-6. PubMed ID: 9796834
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme gene expression in skeletal muscle in patients with chronic heart failure.
Schaufelberger M; Drexler H; Schieffer E; Swedberg K
J Card Fail; 1998 Sep; 4(3):185-91. PubMed ID: 9754589
[TBL] [Abstract][Full Text] [Related]
17. Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.
Ferrari R; Guardigli G; Ceconi C
Cardiovasc Drugs Ther; 2010 Aug; 24(4):331-9. PubMed ID: 20577898
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin, bradykinin and the endothelium.
Dimitropoulou C; Chatterjee A; McCloud L; Yetik-Anacak G; Catravas JD
Handb Exp Pharmacol; 2006; (176 Pt 1):255-94. PubMed ID: 16999222
[TBL] [Abstract][Full Text] [Related]
19. Circulating versus local angiotensin II in blood pressure control: lessons from tissue-specific expression of angiotensin-converting enzyme (ACE).
Xiao HD; Fuchs S; Frenzel K; Teng L; Bernstein KE
Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):137-45. PubMed ID: 15104531
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition: prospects for the future.
Jackson B; Mendelsohn FA; Johnston CI
J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S4-8. PubMed ID: 1725200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
